Author

Shivani Yalala

University of HelsinkiORCID 0009-0007-6105-8563Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Alessia Marin· 1 shared Harri M. ItkoneniD· 1 shared Joyeeta Chatterjee· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

3 top collaborators · 3 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alessia Marin

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyMolecular OncologyPeer-reviewedSep 2, 2026

Castration-resistant prostate cancer cells are addicted to the high activity of cyclin-dependent kinase 2

Joyeeta Chatterjee, Alessia Marin, Shivani Yalala, Harri M. Itkonen

This study identifies CDK2 as a therapeutic target in castration-resistant prostate cancer and shows that combining CDK2 inhibitors with AR inhibitors enhances efficacy without harming normal cells.

DOI 10.1002/1878-0261.70319

humanbulk RNA-seq

𝕏 PostBluesky